Visit Provider
  • Flat-rate pricing · Savings with longer plans
  • Cancel anytime
  • Prescription included · 100% online · No lab work required · Free consultation
  • Multiple pharmacy options
  • Free shipping · Discreet packaging
  • Tirzepatide, Semaglutide · Zepbound, Wegovy
  • Available in all 50 states with some pharmacy restrictions
  • Best pricing requires prepaid commitment · Pricing varies by pharmacy
  • Auto-renewing plans
  • Video consultation required
  • Mixed additive-free options

Provider Plans

Injectable Plan
TirzepatideMonthly
$349/avg
PharmacyTailor Made Compounding (503A)
Precision Medicine (503A)Curexa (503A)Valiant (503A)Innovation Compounding (503A)Everwell Specialty (503A)
AdditivesGlycine
PreservativeBenzyl Alcohol
Based on 503A
BUD (Shelf Life)90 Days
Based on 503A
BillingMonthly
CommitmentNo Commitment
Other FeesNo Extra Fees
Auto-RenewsYes
DoseYour SupplyYour PriceYour SupplyAvg/moYour Value
2.5mg/wk10mg/mo$349.0010mg$349$34.90/mg
5.0mg/wk20mg/mo$349.0020mg$349$17.45/mg
7.5mg/wk30mg/mo$349.0030mg$349$11.63/mg
10.0mg/wk40mg/mo$349.0040mg$349$8.72/mg
12.5mg/wk50mg/mo$349.0050mg$349$6.98/mg
15.0mg/wk60mg/mo$349.0060mg$349$5.82/mg
Injectable Starter Plan
TirzepatideStarter
Starter Sale: $70 off$279/avg
PharmacyTailor Made Compounding (503A)
Precision Medicine (503A)Curexa (503A)Valiant (503A)Innovation Compounding (503A)Everwell Specialty (503A)
AdditivesGlycine
PreservativeBenzyl Alcohol
Based on 503A
BUD (Shelf Life)90 Days
Based on 503A
BillingMonthly
CommitmentNo Commitment
Other FeesNo Extra Fees
Auto-RenewsYes
DoseYour SupplyYour PriceYour SupplyAvg/moYour Value
2.5mg/wk10mg/mo$279.00$349.0010mg$279$27.90/mg
5.0mg/wk20mg/mo$279.00$349.0020mg$279$13.95/mg
7.5mg/wk30mg/mo$279.00$349.0030mg$279$9.30/mg
10.0mg/wk40mg/mo$279.00$349.0040mg$279$6.97/mg
12.5mg/wk50mg/mo$279.00$349.0050mg$279$5.58/mg
15.0mg/wk60mg/mo$279.00$349.0060mg$279$4.65/mg
Sale price included · Converts To After Term
Zepbound Access Plan
TirzepatideMonthlyBrand
$364-$514/avg
PharmacyLillyDirect (Brand)
AdditivesNone
Preservativevaries by formulation
BUD (Shelf Life)30 Days
BillingMonthly
$65 Ongoing Care
CommitmentNo Commitment
Other FeesNo Extra Fees
Auto-RenewsYes
DoseYour SupplyYour PriceYour SupplyAvg/moYour Value
2.5mg/wk10mg/mo$364.0010mg$364$36.40/mg
5.0mg/wk20mg/mo$464.0020mg$464$23.20/mg
7.5mg/wk30mg/mo$514.0030mg$514$17.13/mg
10.0mg/wk40mg/mo$514.0040mg$514$12.85/mg
12.5mg/wk50mg/mo$514.0050mg$514$10.28/mg
15.0mg/wk60mg/mo$514.0060mg$514$8.57/mg
Ongoing care fee included
Microdosing Plan
TirzepatideBundle
$159/avg
PharmacyTailor Made Compounding (503A)
Precision Medicine (503A)Curexa (503A)Valiant (503A)Innovation Compounding (503A)Everwell Specialty (503A)
AdditivesGlycine
PreservativeBenzyl Alcohol
Based on 503A
BUD (Shelf Life)90 Days
Based on 503A
BillingPaid Upfront
Commitment4-Month Supply
4-Month Prepaid
Other FeesNo Extra Fees
Auto-RenewsYes
DoseYour SupplyYour PriceYour SupplyAvg/moYour Value
2.5mg/wk--------
5.0mg/wk--------
7.5mg/wk--------
10.0mg/wk--------
12.5mg/wk--------
15.0mg/wk--------
Dose steps up on a set schedule

Provider Details

Fully Online Care

In-House Rx
Prescription IncludedYes
Telehealth IncludedYes
Online-Only OptionYes
Skip LabsYes

Self-Pay

CreditStarter Sale: up to $150 off
Insurance AcceptedNo
HSA/FSA AcceptedNot Disclosed
Financing AvailableNot Disclosed
SaleYes

Trust

Trustpilot 4.4200,000+ Patients
LegitScript CertifiedNot Disclosed
HIPAA CompliantYes
Mobile AppNot Disclosed

Free Shipping

Cold-Packed
Free ShippingYes
Expedited ShippingNo
Discreet PackagingYes

Tirz + Sema · 503A, BRAND

Format: InjectionBrands: Wegovy · Wegovy Pill · Zepbound
Offers TirzepatideYes
Offers SemaglutideYes
Offers BrandYes
Other TreatmentsYes

Provider Notes

Compliance

Compounded GLP-1 dosing protocols (Microdosing GLP-1) have not been FDA-approved for safety, efficacy, or quality. Compounding permitted under FDA shortage-resolution rules for identified patients.

The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.

General

Longevity-medicine platform where GLP-1 is one of 30+ treatments.

BMI 27+ is considered case by case, BMI 30+ is likely eligible.